Гомеовокс

Quick links to important sections

Гомеовокс

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Гомеовокс

Quick Facts

Property Description
Active ingredients Eleven homeopathic substances (e.g., Aconitum napellus, Ferrum phosphoricum )
Form Coated tablets
Pharmacological class Complex Homeopathic Medicinal Preparation
Common use Symptomatic relief for voice disorders (hoarseness, vocal fatigue)
Origin Natural-derived

The medicinal preparation Гомеовокс (Homeovox) is defined by its specific pharmacological classification and multicomponent composition, establishing its identity and general purpose for supportive care of the voice.

Defining Гомеовокс: Pharmacological Class and Form

Гомеовокс is classified as a complex homeopathic medicinal preparation, meaning it's a multicomponent product combining eleven active substances prepared in high dilutions. It is an Over-The-Counter (OTC) remedy, primarily associated with the BOIRON manufacturer, supplied as small, coated tablets intended for oral administration. This pharmacological classification dictates that the medicine operates under the principles of homeopathy, using diluted substances to stimulate the body's natural regulatory responses rather than high-concentration chemical intervention. Гомеовокс is often positioned for a broad patient group, including children aged two years and older, who require support for voice issues.

Composition and Nature of Active Ingredients

This preparation is a combination product that utilizes eleven active ingredients, sourced from the plant, mineral, and chemical kingdoms. These substances include: Aconitum napellus, Arum triphyllum, Ferrum phosphoricum, Calendula officinalis, Spongia tosta, Belladonna, Mercurius solubilis, Hepar sulfur, Kalium bichromicum, Populus candicans, and Bryonia. Each component is prepared in specific homeopathic potencies, such as the 3CH or 6CH centesimal dilutions. The use of multiple ingredients is a distinguishing feature, aiming to address various symptomatic causes of voice discomfort simultaneously.

General Purpose and Benefit for Voice Disorders

The primary, high-level purpose of Гомеовокс is to offer symptomatic support for voice disorders. It is traditionally utilized to help relieve common issues such as hoarseness (dysphonia) and the sensation of vocal cord fatigue, for instance, after a period of prolonged public speaking or excessive singing. The formula is clinically recognized for its traditional application in reducing the severity and duration of voice changes. The action is supportive and non-drowsy, intended to assist the body's processes in restoring comfortable vocal function.

What side effects are possible with Гомеовокс?

Possible Side Effects and Safety Information

The official regulatory safety profile for Гомеовокс is primarily defined by specific contraindications and restrictions rather than a categorized list of adverse drug reactions (ADRs). Regulatory documents state that, like all medicines, this preparation may cause side effects, though no specific adverse reactions are formally classified by frequency (e.g., common, uncommon) or grouped by System-Organ Class (e.g., gastrointestinal, neurological).


Regulatory Safety Restrictions

Restriction Category Official Safety Statement
Hypersensitivity The medicine is contraindicated in individuals with a known allergy or hypersensitivity to the active substances or any of the excipients (components) contained in the coated tablets.
Pediatric Use Use is formally restricted and contraindicated for children under six years of age, primarily due to the tablet form presenting a risk of aspiration.
Excipient Risk The product contains lactose and sucrose. It is not recommended for use in patients with rare hereditary disorders, such as galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption syndrome, or sucrase-isomaltase insufficiency.

Population-Specific Notes

Official labeling includes specific notes for certain populations. The use of Гомеовокс in pregnant or lactating women should be avoided as a precautionary measure due to the absence of specific clinical and experimental data regarding its effects in these populations. No specific dose- or exposure-related safety patterns are explicitly documented in regulatory sources, meaning no statement exists indicating that effects are more likely at treatment initiation or with long-term use. This safety structure focuses on controlling risks related to composition and administration form, as formally documented by regulatory authorities.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially required actions and documented information concerning an overdose of Гомеовокс (Homeovox), a complex homeopathic medicinal preparation. Regulatory guidance for this product focuses on immediate procedural response rather than specific toxicological symptoms, due to the highly diluted nature of its active ingredients.

Official Regulatory Stance

Information Domain Official Regulatory Status
Documented Manifestations None. Official labeling does not document specific clinical signs, symptoms, or serious outcomes from an overdose of the active components.
Specific Antidote Not documented. No specific antidote is listed in the official prescribing information.

Required Emergency Actions

The primary instruction mandated by regulatory authorities emphasizes immediate help-seeking upon suspected over-ingestion of the finished product, particularly in children. The official statements are:

  • Seek immediate medical attention or get medical help right away if a large quantity of tablets is accidentally swallowed.
  • Contact a poison control centre or a hospital emergency department immediately for guidance on management. The specific steps for supportive management are deferred to the poison control centre or medical professional.

There are no population-specific overdose considerations documented in the official regulatory labels beyond the general and immediate instruction to seek medical assistance.

Therapeutic Uses of Гомеовокс

What Гомеовокс Treats: Main Uses and Benefits

Гомеовокс is a supportive preparation applied across domains where additional symptomatic support is needed for the voice and laryngeal system. It is commonly used to help with symptoms that interfere with daily functioning.

Hoarseness, Dysphonia, and Complete Voice Loss

The traditional uses include the management of symptoms related to vocal quality degradation, including general hoarseness, a strained or raspy voice, and even the temporary loss of voice (aphonia). It may assist with regaining vocal function and is applied in addressing symptoms that create noticeable physiological strain.

Vocal Cord Fatigue and Strain from Overuse

This therapeutic domain helps address symptom clusters that become more disruptive during flare-ups due to excessive voice use, such as symptoms related to organ-specific functional stress, such as vocal fatigue. It is relevant for professional voice users (like teachers and singers) and others who depend on their voice, and provides support that helps ease the overall symptom burden.

Supportive Care for Laryngitis and Acute Irritation

Гомеовокс is applied in conditions characterized by periods of heightened symptoms associated with acute laryngeal irritation or inflammation, generally seen as a symptom of laryngitis. It provides symptomatic assistance during these challenging phases, supports patients during episodes of heightened discomfort, and contributes to improved comfort during symptomatic periods.

Quick Fact: Relief for Vocal Discomfort
Typical Contexts: Voice strain from public speaking, hoarseness from seasonal colds, and vocal fatigue in professional voice users.
Primary Symptom Focus: Hoarseness, temporary loss of voice, vocal cord fatigue, and acute laryngeal irritation.

Regulatory References

  1. Agence nationale de sécurité du médicament et des produits de santé (ANSM)

Eligibility and Restrictions for Use

Who Can and Cannot Use Гомеовокс?

Official regulatory documents define the eligible population for Гомеовокс based on age, allergies, and specific pre-existing health conditions. This information determines who is permitted to use the medicine and for whom it is contraindicated.


Eligibility Scope

The medicine is restricted to adults aged 18 years and older. It is not approved for use in children or adolescents under this age.


Formal Contraindications (Must Not Use)

Use of Гомеовокс is formally contraindicated (prohibited) for the following populations, based on official regulatory labeling:

  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to the active substances or any of the inactive ingredients (excipients) in the product.
  • Metabolic Disorders: Patients with specific rare hereditary problems of carbohydrate metabolism, including:
    • Hereditary galactose intolerance.
    • Lapp lactase deficiency.
    • Glucose-galactose malabsorption.

Pregnancy and Lactation

Eligibility for use during pregnancy and breastfeeding is not fully established or generally recommended, as its safety profile has not been adequately documented for these specific states.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Information

Regulatory documentation for this homeopathic medicine, Гомеовокс (Homeovox), provides a definitive statement regarding its potential to interact with other medications.

Interaction Scope

The primary characteristic of the interaction profile for Гомеовокс is the absence of specific, documented interaction data in official labeling. This means that government-approved product information does not list any specific interacting medicinal products, substance classes, or known mechanistic bases (such as effects on specific enzymes or transporters) that would necessitate restrictions on use.

Category Regulatory Status
Specific Interacting Medicines None explicitly listed
Interacting Substance Categories None identified
Mechanistic Basis of Interaction Not stated/Not applicable

Interaction-Related Constraints

Official regulatory statements confirm that the use of this homeopathic medicinal product does not exclude concurrent treatment with other medicines. Therefore, no formal timing-based restrictions or population-specific interaction constraints are mandated in the labeling. Patients should generally be aware that while no specific drug-drug interactions are documented in the official monograph, this statement reflects the current state of regulatory reporting rather than an exhaustive clinical assessment of all possible combinations.

Conclusion: The regulatory profile indicates that Гомеовокс may be used alongside other treatments without specific restriction, based on the lack of formal, documented interaction warnings.

Mechanism of Action

How Гомеовокс Works

Local Defense and Signaling Modulation

The mechanism involves acting as a modulator of Cellular Sentinel Systems and regulatory cells in the mucosal tissues. This biological signal influences early-stage inflammatory and defense pathways, modulating the response magnitude in the local tissue environment, thereby contributing to homeostatic regulation.


Systemic Adaptive Regulation

The action extends to boosting the body's Systemic Adaptive Regulation by triggering pathways associated with stress resistance and antioxidant capacity. By enhancing these homeostatic mechanisms, the preparation contributes to the maintenance of functional integrity in the tissues and enhances the organism's capacity for homeostatic regulation in response to physiological challenge.


Multi-Component Synergistic Activity

The presence of multiple components creates a multi-target network modulation. This is theorized to provide a broader range of biological signals, allowing for synergistic action across related physiological axes. The mechanism promotes a regulated state within related biological systems, which is a consequence of the functional equilibrium in the relevant regulatory systems.

Dosage and Administration Information

How to Use Гомеовокс: Official Administration Guidelines

The following guidelines delineate the standardized usage protocol for Гомеовокс (Homéovox) tablets.


Administration Scope

The official route of administration is oral, but the physical form requires a specific technique: the tablets must be sucked slowly or allowed to dissolve completely in the mouth. This buccal administration method is a core requirement of the labeled instructions. Dosing should occur away from meals to ensure the proper contact conditions.

Scenario Dose & Frequency Duration Constraint
Acute Symptoms 2 tablets, repeated approximately every hour initially. Dosing is then spaced out as improvement is noted. Maximum duration of six days in total.
Preventative/Supportive Use 2 tablets, administered five times per day. Must cease use if symptoms persist or worsen after two days.

Population Rules and Procedural Structure

The official use of the coated tablet form is formally reserved for individuals aged 6 years and older. This restriction is tied directly to the administration technique, as younger children may not be able to safely perform the required dissolving procedure.

The overall use protocol is structured as a time-bound, short-term treatment. This protocol strictly defines both the maximum duration and an early cessation condition: if there is no perceived change after two days of self-administration, the product’s use should stop. This ensures that the administration of the preparation adheres to the explicit procedural conditions.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Research on the compound, which is classified as a homeopathic medicine, typically focuses on its use for dysphonia (hoarseness), loss of voice, and symptoms associated with laryngitis. Due to its classification, the evidence base differs from that of conventional pharmaceuticals.


Efficacy and Outcomes

Clinical investigations into the compound often employ an observational or comparative design, evaluating its effect when used alone or in combination with standard treatments for laryngeal conditions.

  • Studies have examined outcomes in adult patients with various types of dysphonia, including acute and chronic catarrhal laryngitis. Results from these studies often report that the compound is associated with changes in the clinical and functional status of the larynx when assessed using subjective and objective methods like videolaryngostroboscopy and acoustic voice analysis.
  • Further research is necessary to confirm the findings of early studies and to clearly establish the clinical significance of these observed changes in symptoms across broader patient populations.

Safety and Tolerability Profile

Acute Toxicity Studies

Preclinical research, such as acute toxicity studies in animal models, has been conducted to determine the potential hazard level of the compound. Findings from these studies generally indicate that the compound belongs to the categories of substances considered practically non-toxic at the maximum administered doses.

Observed Side Effects

As a homeopathic product, the compound is often marketed with claims of high tolerability. The drug monograph (package leaflet) outlines a low risk of side effects, typical of many homeopathic preparations. It is important for individuals to consult the full patient leaflet for a complete overview of potential adverse reactions, special warnings, and information regarding excipients like lactose and sucrose.

Frequently Asked Questions (FAQ)

Common questions about Гомеовокс (FAQ)


Q: How quickly does Гомеовокс typically start working for throat issues?

Official instructions define a specific duration of use for Гомеовокс. Regulatory guidance states that if no improvement in symptoms is noted, use should cease after two days. The official protocol suggests that a user should see some change in symptoms within a short, initial period; otherwise, use should be stopped.


Q: Can children of all ages use Гомеовокс?

No, official regulatory documents state a formal restriction regarding age. Гомеовокс is contraindicated (prohibited) for use in children under six years of age. This safety measure is primarily related to the tablet form presenting a potential risk of aspiration in very young children.


Q: Is there any sugar or lactose in the composition of Гомеовокс?

According to the official labeling, the product contains both lactose and sucrose. The presence of these excipients (inactive ingredients) means the medicine is not recommended for patients with specific rare hereditary metabolic disorders, such as certain intolerances to galactose or glucose.


Q: Does Гомеовокс need to be dissolved or can it be swallowed whole?

The official administration technique is a required condition of use for the product. Regulatory information mandates that the tablets must be sucked slowly or allowed to dissolve completely in the mouth. The tablets are not intended to be swallowed whole, as the administration method requires buccal dissolution.


Q: What is the general patient expectation for symptom relief with Гомеовокс?

Studies and official information indicate that the compound is associated with changes in the clinical and functional status of the larynx (voice box). However, further research is necessary to clearly establish the overall clinical significance of these observed changes in symptoms. It is used for symptomatic support.


Q: Does official literature mention any risks for people with liver or kidney conditions?

Official regulatory safety restrictions for Гомеовокс focus on allergies, age, and metabolic disorders. The product monograph does not list specific contraindications related to pre-existing liver or kidney conditions.


Q: Can I use Гомеовокс if I am already taking herbal supplements?

Regulatory documentation provides the definitive statement that there is an absence of specific, documented interaction data in official labeling for use with other medicinal products. Official labeling does not list specific, documented interactions with other medicinal products or herbal supplements.


Q: Is Гомеовокс known to cause drowsiness or affect driving?

Official safety documents do not list drowsiness or specific central nervous system (CNS) effects. Official safety documents do not contain a warning regarding drowsiness or impairment of the ability to drive or operate machinery.


Q: What happens if I accidentally take more Гомеовокс than the label suggests?

In cases of accidental overdose or ingestion, official regulatory guidance advises contacting a healthcare professional or a poison control center. This guidance applies to all situations where a person takes more than the suggested amount.


Q: Can Гомеовокс be used during seasonal changes or just when symptoms are present?

The official administration protocol includes two distinct schedules. One is for acute, currently present symptoms, and the other is for a Preventative or Supportive Use. This structure allows for use outside of acute symptomatic periods.


Q: Does Гомеовокс have an expiration date, and is it still okay to use past that date?

Like all licensed medicines, the product is assigned a batch-specific expiration date which is printed on the packaging. Unused or expired product must be returned to a pharmacy or utilized a designated collection system for pharmaceutical waste, and are officially required to be disposed of through a designated collection system, not used.


Q: Are there specific food or drink types that might affect how Гомеовокс works?

Official administration instructions specify a timing constraint for use. Dosing is required to occur away from meals to ensure the proper contact conditions in the mouth, which are necessary for the buccal administration method.


Q: Is Гомеовокс generally considered gentle on the stomach?

Official labeling focuses its safety warnings on age, allergies, and metabolic disorders related to excipients. The product monograph does not list common or specific gastrointestinal adverse reactions (e.g., stomach upset) with a defined frequency.


Q: What should I do if a side effect of Гомеовокс seems concerning?

If a side effect is noted or becomes concerning, regulatory guidance advises consulting with a healthcare professional or a pharmacist. Patients are advised to seek appropriate assessment and advice from a medical professional.


Q: How does the official guidance describe the mechanism of action for Гомеовокс?

Official guidance describes the mechanism as a multi-component synergistic activity. It functions as a modulator of cellular sentinel systems and regulatory cells in mucosal tissues, aiming to restore homeostatic regulation (the body's process for maintaining balance) in related biological systems.


Q: Does Гомеовокс contain any ingredients sourced from animals?

The excipient list includes lactose, which is derived from milk. The presence of this ingredient means that the product contains materials sourced from animals.


Q: What are the potential risks of using Гомеовокс with heart medication?

Regulatory documentation provides the definitive statement that there is an absence of specific, documented interaction data in official labeling for use with other medicines. Therefore, no formal timing-based restrictions or constraints regarding heart medication are mandated in the labeling.


Q: Is the packaging of Гомеовокс child-resistant?

Official regulatory guidelines mandate specific safety instructions for storage. The product must be kept out of the sight and reach of children, which is the primary regulatory safety instruction regarding minors and packaging.


Q: Are there different forms of Гомеовокс (e.g., liquid, tablets)?

Official regulatory documents define the single licensed pharmaceutical form of this product as coated tablets intended for buccal/oral administration. No other forms, such as a liquid, are referenced in the official monographs.


Q: Is Гомеовокс suitable for vegetarians or vegans?

Because the product contains lactose, which is derived from milk, it is not suitable for individuals following a vegan diet. The product's excipient profile is generally compatible with diets that allow for milk derivatives.


Q: Is there a maximum age limit for using Гомеовокс?

Official regulatory documents define the eligible population for the product as adults aged 18 years and older (in some jurisdictions). While there is a formal minimum age restriction, the labeling does not state a specific maximum age limit for use.


Q: Does Гомеовокс contain gluten?

Official regulatory warnings list excipients like lactose and sucrose for metabolic concerns. However, the official documentation does not include a specific warning or contraindication related to gluten-containing ingredients.


Q: What is the policy for reporting adverse reactions to Гомеовокс?

Official regulatory guidance requires patients to take action if they suspect a side effect. Patients are advised to report suspected adverse reactions to their healthcare professional or directly to the national regulatory authority via the applicable reporting scheme.

How should Гомеовокс be stored and disposed of?

How to Store and Dispose of Гомеовокс

Official regulatory guidelines mandate specific storage conditions to ensure the quality and stability of Гомеовокс (Homeovox) tablets. The medicine must be stored at a temperature that does not exceed 25 °C. It is also a requirement that the product be kept in its original container and strictly out of the sight and reach of children.

Storage and Disposal Rule Requirement Type
Maximum Temperature 25 C
Container Rule Keep in Original Container
Child Safety Out of Sight and Reach of Children

For disposal, unused or expired Гомеовокс must not be placed into household waste or poured down a drain. Instead, regulatory instructions specify that the medicine should be returned to a pharmacy or utilized a designated collection system for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Гомеовокс found in:

A-Z Index: